Henry Luke Danahay;Jennifer Leslie Harris;Stéphanie Monnier;Juergen Roettele;Dilraj Singh;Jean-Louis Reber;Silvia Heuerding;Janet Catherine Maas;David C. Tully;Darren Mark LeGrand
发明人:
Henry Luke Danahay,Darren Mark LeGrand,David C. Tully,Jennifer Leslie Harris,Silvia Heuerding,Dilraj Singh,Janet Catherine Maas,Juergen Roettele,Jean-Louis Reber,Stéphanie Monnier
申请号：
US13372984
公开号：
US20120208882A1
申请日:
2012.02.14
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
